Heparanase Blockade as a Novel Dual-Targeting Therapy for COVID-19. Xiang J, Lu M, Shi M, Cheng X, et al. J Virol 2022 Mar 23:e0005722. doi: 10.1128/jvi.00057.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Xiang J, Lu M, Shi M, Cheng X, et al. Heparanase Blockade as a Novel Dual-Targeting Therapy for COVID-19. J Virol 2022 Mar 23:e0005722. doi: 10.1128/jvi.00057.
PMID: 35319225